Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Privi Speciality in Focus: Motilal Oswal Remains Bullish on Strong Growth Story — Check Target Price
The upcoming mergers with Privi Fine Science, Privi BiotechnologiesL and PRIGIV JV with Givaudaare expected to expand Privi's specialty aroma portfolio, which is expected to drive revenue growth, enhance earnings.
Healthcare, engineering and specialty chemicals remain key market themes: Mayuresh Joshi
Mayuresh Joshi, Director Research at Marketsmith India, believes execution will remain key for companies like Suzlon, while healthcare, engineering and select speciality chemical names continue to offer strong growth opportunities. He also sees India-focused engineering and capital goods companies remaining resilient despite global uncertainties. Joshi says investors should stay selective in IT, remains positive on Navin Fluorine, and is closely tracking niche AI-linked opportunities emerging in smaller tech firms.
HMEL to invest Rs 2,600 cr in speciality, fine chemicals sector in Punjab: LN Mittal
HPCL-Mittal Energy Limited (HMEL) announced a Rs 2,600 crore investment in Punjab's speciality and fine chemicals sector. Additionally, HMEL plans to launch 500 new retail fuel outlets nationwide, equipped with modern technology. This expansion follows HMEL's significant Rs 60,000 crore investment in its Bathinda refinery, Punjab's sole oil refinery.
Balaji Amines' plants closed as West Asia war hits ammonia supply
The speciality chemicals maker said some of its plants have become non-operational due to disruptions in the supply of ammonia, a key raw material, with certain key suppliers invoking the force majeure clause. Shares of Balaji Amines Ltd ended at ₹1,047.55, up by ₹4.85, or 0.47%, on the BSE today, March 12.
Anupam Rasayan completes USD150-mln acquisition of US speciality chemical maker Jayhawk
Anupam Rasayan India has acquired US-based Jayhawk Fine Chemicals Corporation for approximately USD 150 million. This strategic move aims to broaden Anupam Rasayan's global presence and access new end-use markets. The acquisition is expected to enhance its integrated platform and create cross-selling opportunities. Jayhawk's operations in performance materials will now be consolidated into Anupam Rasayan's financials.
Buy Privi Speciality Chemicals; target of Rs 3900: Motilal Oswal
Motilal Oswal is bullish on Privi Speciality Chemicals recommended buy rating on the stock with a target price of Rs 3900 in its research report dated Jun 10, 2026.